12:00 AM
 | 
Aug 23, 2010
 |  BC Week In Review  |  Company News  |  Other News

International Stem Cell ophthalmic, gene/cell therapy news

International Stem Cell formed business unit Cytovis to focus on the company's CytoCor and CytoRet ophthalmic...

Read the full 70 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >